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INTRODUCTION
A chronic increase in reactive oxygen species (ROS) plays a critical role in the development and progression of cardiac remodeling associated with heart failure [1] . Oxidative stress is indeed increased in heart failure, hypertension, cardiac fibrosis and hypertrophy [2] [3] [4] . In vitro exposure of cardiac fibroblasts to superoxide anion stimulates their proliferation by increasing the production of transforming growth factor-β 1 (TGF-β 1 ), a potent fibrogenic cytokine [5] .
Ventricular fibroblasts activation and cardiac fibrosis are primary events in ventricular remodeling rather than secondary to cardiomyocyte injury [6] . In normal cardiac tissue collagen synthesis and deposition are exclusively carried out by cardiac fibroblasts with relatively low turnover of extracellular matrix proteins [7] . Contractile myofibroblasts are the relevant phenotypic variants in wound healing or in hypertrophied and failing hearts [7] [8] [9] . Signals for fibroblasts to myofibroblasts phenoconversion are TGF-β 1 and mechanical loading. An increase in α-smooth muscle actin (α-SMA) in these cells is a marker of myofibroblasts and is synonymous with enhanced contractile force generation [10] . An increased α-SMA expression is also found in myofibroblasts in fibrotic hearts after volume or pressure overload or in the infarct scar of postmyocardial infarction hearts [7] .
Previously we have shown, in adult rat cardiac fibroblasts, that TGF-β 1 induces the differentiation of fibroblasts to myofibroblasts, which have a higher activity for collagen production than fibroblasts [11] . ROS are also released during the phenotypic transformation of fibroblasts to myofibroblasts and are important in the control of collagen production [12, 13] . The angiotensin II-stimulated production of collagen and ROS in cardiac fibroblasts is blocked by the membrane associated NADPH oxidase inhibitor, apocynin and diphenyleneiodonium chloride (DPI) [14, 15] . Exposure of cardiac fibroblasts to the superoxide inhibitor diethyldithiocarbamic acid (DETC) increases superoxide anion and collagen production [15] , indicating a role of the generated ROS in the myocardial accumulation of collagen.
The aim of the present study was to determine the role of ROS in the TGF-β 1 -induced collagen production and differentiation of cardiac fibroblasts into myofibroblasts.
MATERIALS AND METHODS

Cell cultures
All animal procedures were in accordance with the laws, regulations and administrative provisions of the Member States of the European Community (Council Directive 86/609/EEC of November 24, 1986) regarding the protection of animals for experimental and other scientific purposes. This research protocol was also approved by the Ethical Committee for Animal Experiments of the Catholic University of Leuven (KULeuven), Belgium.
Cardiac ventricular fibroblasts obtained from male adult Wistar rats were grown in Dulbecco's modified Eagle's medium (DMEM) in the presence of 10% fetal bovine serum (FBS) and used in passage 2 as previously described [11] . When cultures reached confluence, the medium was replaced with fresh phenol red free DMEM with 0% FBS for 24 h. The cells, identified as proliferative myofibroblasts [16] were then preincubated with(out) the tested inhibitors for 1 h and then further incubated with(out) TGF-β 1 (600 pmol/l) for 0.5, 1, 2, 4, 24 or 48 h in this medium.
Immunoblot
Western blotting [15] was performed in cell lysates and cytosolic extracts prepared by NE-PER extraction reagents (Pierce Biotechnology, Rockford, IL, USA). Antibodies for α-SMA and for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from Sigma Chemicals Co. (St. Louis, MO, USA) and the corresponding secondary HRP-conjugated antibodies from Chemicon Inc. (Temecula, CA, USA).
Collagen assay
Collagen production was assayed as [ 3 H]proline incorporation and expressed as desintegrations/min per 10 6 cells [17] , and using the Sircol assay (Biocolor, Belfast, Northern Ireland) and expressed as µg/10 6 cells [15] . Soluble collagen has been measured in the conditioned medium and non-soluble collagen in the cell layer.
Assay of reactive oxygen species.
A fluorescent probe, 2',7'-dichlorofluorescein diacetate (DCF-DA) was used for the assessment of intracellular [18, 19] ROS formation (such as hydrogen peroxide, hydroxyl and peroxyl radicals and hydroperoxides) in cardiac fibroblasts treated with(out) TGF-β 1 .
Statistical analysis
Values are expressed as mean ± SEM. The statistical methods used were repeated measures of variance (Tukey's) and Students 2-tailed test for (un)paired data when appropriate. A value of P < 0.05 was considered statistically significant.
RESULTS
TGF-β 1 -induced collagen production in cardiac fibroblasts
TGF-β 1 at concentrations from 1 to 600 pmol/l induced a dose-dependent increase in the production of soluble and non-soluble collagen after 48 h of incubation (Fig.1A) . In the concentration range from 0.12 to 40 pmol/l, TGF-β 1 did not affect the soluble collagen production. A maximal increase in soluble collagen production was obtained at 600 pmol/l or 15 ng/ml. No significant effect of TGF-β 1 (600 pmol/l) on soluble collagen production was found after 1, 2 and 4 h of incubation ( Fig.2A) . After 24 and 48 h TGF-β 1 significantly (P < 0.01) stimulated soluble collagen production (2.5-and 4.7-fold, respectively).
TGF-β 1 upregulation of α-SMA in cardiac fibroblasts
TGF-β 1 dose-dependently induced an increase in the protein expression of α-SMA, a marker of myofibroblasts (Fig.1B) .
The induction of α-SMA by TGF-β 1 after 24 and 48 h is 2.5-and 5-fold, respectively (Fig.2B) . No induction of α-SMA is found after 1, 2 and 4 h. The TGF-β 1 -induced appearance of α-SMA paralleled with the TGF-β 1 stimulated soluble collagen production
TGF-β 1 stimulation of ROS production in cardiac fibroblasts
To determine whether TGF-β 1 stimulates the intracellular ROS production, cardiac fibroblasts treated with TGF-β 1 were incubated with DCF-DA, a peroxide-sensitive dye to DCF-DA oxidation as a measure of levels of intracellular ROS. Intracellular ROS production was not affected by TGF-β 1 after 0.5 and 1 h of incubation, began to rise significantly after 2 h, and reached a maximal increase (2.2 ± 0.5 fold, P < 0.05) after 4 h (Fig.3) . The increase in ROS production preceded the rise in collagen production and α-SMA production.
The TGF-β 1 -stimulated ROS production is reduced (P < 0.05) by DPI, an inhibitor of flavin-containing oxidoreductases such as NADPH oxidase; by tempol, a superoxide dismutase mimetic and ROS scavenger and by N-acetylcysteine (NAC), a glutathione precursor and scavenger of H 2 O 2 (Fig.4) . DPI and NAC, but not tempol, inhibited the ROS production in control fibroblasts (Fig.4) . 
TGF-β 1 upregulation of collagen and α-SMA is ROS-sensitive
Previously we have shown that the soluble collagen production in basal cardiac fibroblasts is reduced by ROS inhibitors such as DPI [14] , apocynin [14] tempol [15] and EUK-8 (a superoxide dismutase and catalase mimetic) [15] . The TGF-β 1 -stimulated soluble collagen production (30.1 ± 5.9 µg/10 6 cells) compared to control (n = 4) cardiac fibroblasts (12.6 ± 0.4 µg/10 6 cells) is also reduced (P < .05) by DPI to 9.1 ± 0.9 µg/10 6 cells.
To determine whether ROS are necessary for the expression of α-SMA in response to TGF-β 1 , cardiac fibroblasts were treated with the ROS inhibitor DPI and then the protein expression of α-SMA was examined.
As shown in Fig.5 , DPI decreased (P < 0.05) the TGF-β 1 -upregulated α-SMA protein expression by 31.4 ± 3.2% (n = 4). 
DISCUSSION
The present in vitro study in adult rat cardiac fibroblasts has shown that TGF-β 1 increased the intracellular ROS production and this rise precedes the TGF-β 1 -stimulated collagen production and α-SMA expression (Figs.2&3) . TGF-β 1 is a multifunctional cytokine that participates in many cellular functions such as control of growth, proliferation, differentiation and apoptosis. In the cardiovascular system TGF-β 1 plays pivotal roles in the pathogenesis of hypertension, restenosis after percutaneous coronary intervention, atherosclerosis, cardiac hypertrophy and heart failure [20] . TGF-β 1 contributes to pathogenic cardiac remodeling via increased ROS formation and cellular redox imbalance.
Accumulating evidence supports a causative role of oxidative stress in various tissues including liver, lung, arteries, nervous system and heart [14, 15, 21, 22] . Indeed, ROS are shown to upregulate the expression of TGF-β 1 and collagen type I in various tissues [23, 24] .
In vitro studies have shown that ROS promote collagen type I gene expression and fibroblast proliferation in cardiac fibroblasts [25] .
The stimulatory effect of TGF-β 1 on ROS production has been demonstrated in bovine pulmonary artery endothelial cells, human lung and cardiac fibroblasts [26] . In rat ventricular myocytes TGF-β 1 (1 ng/ml) for 3-4 h increased ROS production by 90% and decreased intracellular glutathione (GSH ic ) by 34%; both changes were prevented by DPI, an inhibitor of flavincontaining oxidoreductase such as NADPH oxidase, or by Mn(III)terakis(1-methyl-4-pyridyl)porphyrin-pentachloride (MnTMPyP), a free radical scavenger [27] . The changes in ROS and GSH ic paralleled a decrease in the rate of myocyte shortening and relaxation, whereas fractional shortening was not affected. The TGF-β 1 -induced cardiomyocyte contractile dysfunction is associated with enhanced ROS production and oxidative alterations in Ca handling proteins regulated by endogenous GSH.
Antioxidants however reduce cardiac TGF-β 1 expression, induced by angiotensin II infusion, which sequentially attenuated the differentiation of myofibroblasts, type I collagen synthesis and matrix metalloproteinase inhibition, thus attenuating cardiac fibrosis [28] .
The superoxide anion mediates the conversion of skin fibroblasts into myofibroblasts via paracrine release of TGF-β 1 in a skin model of wound healing [29] . In primary human cardiac fibroblasts Cucoranu et al [13] have shown that TGF-β 1 -upregulated α-SMA expression is abrogated by DPI, by NAC (a glutathione precursor and scavenger of H 2 O 2 and by ebselen (a nonspecific H 2 O 2 scavenger).
The present study also shows that DPI decreased the conversion of adult rat cardiac fibroblasts to myofibroblasts. A recent study also reveals that tryptase, a cardiac mast cell product, induces a cardiac myofibroblastic phenotype and is implicated in the development of cardiac fibrosis [30] .
Our in vitro data indicate that ROS are involved in the TGF-β 1 -induced collagen production and appearance of myofibroblasts in cardiac fibroblasts and suggest a role of ROS in the modulation of TGF-β 1 -induced myocardial remodeling.
